Samsara Therapeutics
Warren Galloway is the Vice President of Chemistry at Samsara Therapeutics. He is a Fellow Emeritus at Pembroke College, University of Cambridge. He has 72 publications in chemistry and chemical biology, including in diversity-oriented synthesis. Dr. Galloway undertook his postdoc in the David Spring lab at Cambridge. He received his B.A., M.A., and PhD in organic chemistry at the University of Cambridge.
This person is not in any offices
Samsara Therapeutics
Samsara Therapeutics, Inc. is a biopharmaceutical company aiming to discover the first-in-class therapeutics that treat rare genetic and neurodegenerative diseases and extend a healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy.